Bacil Pharma Ltd

524516

Summary

Price Down by |%
Chart Data Not Available

Business Description
Bacil Pharma Ltd is an Indian-based pharmaceutical company operating in a single segment. It is engaged in the manufacturing of pharmaceuticals, medicinal chemicals, and botanical products. The company manufactures, exports, supplies, and retail Anti Anxiety Medicine, Antihistamines, Chemical Compound, Drugs and Herbal Tablets, and Capsules.
Contact
Sir P. M. Road No. 71, Laxmi Building, 4th Floor, Mumbai, MH 400 001
T +91 2222618452
www.bacilpharma.co.in opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
3

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in null, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
Revenue Growth %
Gross Profit
Gross Profit Margin %
Operating Income
Operating Margin %
EBIT
EBIT Margin %
EBITDA
EBITDA Margin %
Net Income
Net Profit Margin %
Basic EPS
0.69 0.69 -0.10 -0.17 -6.55 -0.41
Diluted EPS
0.69 0.69 -0.10 -0.17 -6.55 -0.41
Normalized EPS
Total Dividends per Share
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Mil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
256.00 256.00 13.26 11.27 12.72 40.88
Total Liabilities
1.69 1.69 1.13 0.28 0.47 26.97
Total Debt
1.64 1.64 0.98 0.21 0.33 1.76
Total Equity
254.31 254.31 12.13 10.99 12.24 13.91
Cash And Cash Equivalents
28.57 28.57 0.41 0.29 2.30 0.99
Working Capital
27.39 27.39 -0.61 2.01 4.54 -23.95
Shares Outstanding (Mil)
5.89
Book Value Per Share
43.18 43.18 2.06 1.87 2.08 2.36
Total Debt To Equity
0.01 0.01 0.08 0.02 0.03 0.13
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Mil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
4.01 -0.03 -1.47 -40.09 -3.98 -3.78
Cash From Investing Activities
3.37 0.78 -1.16 38.12 5.28 3.87
Cash From Financing Activities
20.78 -0.63 0.63 3.27 -0.73 -0.56
Capital Expenditures
Free Cash Flow
3.84 -0.86 -1.29 -39.14 -3.77 -4.49
Change in Cash
28.16 0.13 -2.01 1.31 0.56 -0.47

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top